ALRN Insider Trading Activity and SEC Form 4 Filings
ALRN insider trading summary
No open-market insider purchases or sales of Aileron Therapeutics, Inc. (ALRN) have been reported on SEC Form 4 in the past 12 months.
Latest ALRN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 5, 2024 | James Brian Windsor | President and CEO | Buy | $535 (239 @ $2.24) |
| Dec 5, 2024 | James Brian Windsor | President and CEO | Buy | $362 (161 @ $2.25) |
| Jun 17, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $15K (4,707 @ $3.25) |
| Jun 14, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $6K (1,900 @ $3.30) |
| Jun 12, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $30K (9,341 @ $3.25) |
| Jun 12, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $3 (1 @ $3.27) |
| Jun 11, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $17K (5,250 @ $3.25) |
| Jun 11, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $2K (502 @ $3.35) |
| Jun 10, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $32K (9,577 @ $3.30) |
| Jun 7, 2024 | University of Texas/Texas Am Investment Management Co | 10% Owner | Sell | $5K (1,564 @ $3.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.